Individual patient data meta-analysis of 4 trials (71,683 patients with AF): systemic embolic events occurred at 0.13% per patient-year; standard-dose NOACs reduced them versus warfarin (HR 0.71, 95% CI 0.51-0.99), and SEE was associated with higher long-term mortality.
Meta-analysisn = 71,683
Al Said et al. Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin